Belle Mead, NJ, United States of America

Lei Tang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sanofi. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Tang. Retrieved from https://idiyas.com/inventor/lei-tang-t00qektz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lei Tang - Innovator in Antibody-Like Proteins

Introduction

Lei Tang is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody-like proteins. His innovative work has led to the filing of a patent that showcases his expertise and creativity in this area.

Latest Patents

Lei Tang holds a patent for the "Uses of a dual V region antibody-like protein." This patent focuses on the applications of a dual V region antibody-like protein or a fragment of such a protein. This invention has the potential to impact various therapeutic approaches in medicine.

Career Highlights

Currently, Lei Tang is employed at Sanofi, a global biopharmaceutical company. His role at Sanofi allows him to work on cutting-edge research and development projects that aim to improve healthcare solutions. His dedication to innovation is evident in his contributions to the field.

Collaborations

Lei Tang collaborates with talented professionals in his field, including Florent C. Bender and Danxi Li. These collaborations enhance the research environment and foster the exchange of ideas, leading to further advancements in biotechnology.

Conclusion

In summary, Lei Tang is an accomplished inventor whose work on antibody-like proteins has the potential to revolutionize therapeutic applications. His contributions at Sanofi and his collaborations with other experts highlight his commitment to innovation in the biotechnology sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…